◀ Back to MAPK15
KITLG — MAPK15
Text-mined interactions from Literome
Jeong et al., Endocrinology 2003
:
Dexamethasone inhibited
SCF induced p38
MAPK activation to near-basal levels and induced MAPK phosphatase-1 expression
Hue et al., Immunol Lett 2005
(Melanoma, Experimental) :
Furthermore, inhibitors of p38 mitogen activated protein kinase ( MAPK ), such as SB203580, blocked enhanced SCF expression, indicating that p38
MAPK activity is
required for IL-18 enhanced
SCF production
Qu et al., Mol Cell Biol 1997
:
Stem cell factor induction of
mitogen activated protein kinase activity was also blocked in Shp-2 mutant cells
Sui et al., Blood 1998
:
Wortmannin only inhibits MAPK activation induced by EPO but not that by SCF, suggesting that
SCF and EPO may
activate MAPK through different pathways, which would facilitate synergy